Bill

Bill > B25-0244


DC B25-0244

DC B25-0244
Prescription Drug Monitoring Program Amendment Act of 2023


summary

Introduced
04/11/2023
In Committee
10/12/2023
Crossed Over
11/07/2023
Passed
12/21/2023
Dead
Signed/Enacted/Adopted
02/23/2024

Introduced Session

25th Council

Bill Summary

AN ACT IN THE COUNCIL OF THE DISTRICT OF COLUMBIA To amend the Prescription Drug Monitoring Program Act of 2013 to expand the authority of the Director of the Department of Health to disclose information related to the prescribing and dispensing of covered substances, and to authorize the Director to charge a fee to offset the operational costs of expanding disclosure to information.

AI Summary

This bill amends the Prescription Drug Monitoring Program Act of 2013 to expand the authority of the Director of the Department of Health to disclose information related to the prescribing and dispensing of covered substances. It allows the Director to disclose aggregate and summary data that has been processed to remove identifying information for statistical, research, educational, or grant application purposes, as well as information for public health surveillance purposes to employees of the Department's Center for Policy, Planning, and Evaluation. The bill also authorizes the Director to charge a fee to offset the operational costs associated with these expanded disclosure activities.

Committee Categories

Health and Social Services

Sponsors (1)

Last Action

Law L25-0125, Effective from Feb 15, 2024 Published in DC Register Vol 71 and Page 001850 (on 02/23/2024)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...